LA
MDCO

Lee Ainslie’s Medicines Co MDCO Stock Holding History

Lee Ainslie’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,176,487
Closed -$185M – 563
2019
Q4 		$185M Sell
2,176,487
-1,707,552
-44% -$114M 2.69% 12
2019
Q3 		$194M Buy
3,884,039
+16,956
+0.4% +$676K 2.85% 12
2019
Q2 		$141M Buy
3,867,083
+52,731
+1% +$1.72M 2.04% 15
2019
Q1 		$107M Buy
3,814,352
+299,375
+9% +$7.06M 1.41% 20
2018
Q4 		$67.3M Buy
3,514,977
+2,150,140
+158% +$50M 0.99% 28
2018
Q3 		$40.8M Buy
1,364,837
+159,556
+13% +$6.01M 0.51% 35
2018
Q2 		$44.2M Buy
1,205,281
+299,030
+33% +$9.72M 0.52% 34
2018
Q1 		$29.9M Buy
+906,251
New +$28.3M 0.39% 35

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Lee Ainslie's MDCO Position: Q1 2020 in Review

Lee Ainslie sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 2,176,487 shares — an estimated $185M sold.

Lee Ainslie first reported a position in MDCO in Q1 2018 and held it in 8 quarters. The position peaked at $194M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Lee Ainslie reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Lee Ainslie sold 2,176,487 Medicines Co shares in Q1 2020, an estimated $185M.
  • Lee Ainslie first reported a position in Medicines Co in Q1 2018 and held it in 8 quarters.
  • Lee Ainslie's Medicines Co position peaked at $194M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Maverick Capital's 13F filing for Q1 2020, filed 15 May 2020.